Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+

BMC Cancer201010:487

DOI: 10.1186/1471-2407-10-487

Received: 2 June 2010

Accepted: 13 September 2010

Published: 13 September 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Jun 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
4 Aug 2010 Reviewed Reviewer Report - Peter Searle
10 Aug 2010 Reviewed Reviewer Report - Donald Buchsbaum
16 Aug 2010 Reviewed Reviewer Report - Matthias Renner
23 Aug 2010 Author responded Author comments - Joshua Doloff
Resubmission - Version 3
23 Aug 2010 Submitted Manuscript version 3
25 Aug 2010 Reviewed Reviewer Report - Matthias Renner
31 Aug 2010 Reviewed Reviewer Report - Peter Searle
12 Sep 2010 Author responded Author comments - Joshua Doloff
Resubmission - Version 4
12 Sep 2010 Submitted Manuscript version 4
Publishing
13 Sep 2010 Editorially accepted
13 Sep 2010 Article published 10.1186/1471-2407-10-487

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Division of Cell and Molecular Biology Department of Biology, Boston University

Advertisement